A 38-year-old man with major depressive disorder and chronic migraine headaches presents for antidepressant therapy. He has failed one trial of fluoxetine due to lack of efficacy. Which agent is the drug of choice for his depression while also providing migraine prophylaxis?

Explanation

## Antidepressant Selection in MDD with Comorbid Migraine **Key Point:** When MDD coexists with chronic migraine, tricyclic antidepressants (TCAs)—particularly amitriptyline—become first-line because they treat both conditions simultaneously. ### Why Amitriptyline in This Context? **High-Yield:** Amitriptyline is the drug of choice when: 1. MDD requires treatment AND 2. Comorbid chronic migraine or tension headache is present 3. Previous SSRI trial has failed **Mechanism of Migraine Prevention:** - Blocks serotonin and norepinephrine reuptake → increases descending inhibition of pain pathways - Stabilizes trigeminal neuron firing - Reduces cortical spreading depression - Effective at doses lower than those needed for depression (10–50 mg for migraine vs. 75–150 mg for MDD) ### Efficacy in Dual Indication | Parameter | Amitriptyline | SSRIs | Mirtazapine | | --- | --- | --- | --- | | **MDD efficacy** | ✓ High | ✓ High | ✓ High | | **Migraine prophylaxis** | ✓✓ Gold standard | ✗ Minimal | ✗ Minimal | | **Evidence level** | Level A (strong) | Level C (weak) | Level C (weak) | | **Onset of migraine benefit** | 2–4 weeks | 8–12 weeks (if any) | Not established | | **Dose for migraine** | 10–50 mg/day | Higher doses needed | Not standard | **Clinical Pearl:** In this patient with SSRI failure (fluoxetine), switching to a TCA with dual efficacy avoids polypharmacy and improves adherence. The anticholinergic and sedating side effects of amitriptyline, which are drawbacks in other populations, become therapeutic benefits in a patient with migraine and insomnia. ### Dosing Strategy for Dual Indication 1. **Start:** 10–25 mg at bedtime 2. **Titrate:** Increase by 10–25 mg every 3–5 days 3. **Migraine prophylaxis:** 30–50 mg/day (achieved in 1–2 weeks) 4. **Depression:** 75–150 mg/day (achieved over 4–6 weeks) 5. **Maximum:** 300 mg/day (rarely needed) **Mnemonic:** **TCA-PAIN** — Tricyclic Antidepressants treat both Psychiatric And INsomnia/migraine comorbidities.